differential role of cyclooxygenase 1 and 2 isoforms in...
TRANSCRIPT
JPET #98350
1
Differential role of cyclooxygenase 1 and 2 isoforms in the modulation of
colonic neuromuscular function in experimental inflammation
Matteo Fornai, Corrado Blandizzi, Luca Antonioli, Rocchina Colucci, Nunzia Bernardini,
Cristina Segnani, Fabrizio De Ponti, Mario Del Tacca
Division of Pharmacology and Chemotherapy, Department of Internal Medicine (M.F, C.B.,
L.A., R.C., M.D.T.), Department of Human Morphology and Applied Biology, Section of
Histology and General Embryology (N.B., C.S.), University of Pisa, Pisa, Italy, Department
of Pharmacology (F.D.P.), University of Bologna, Bologna, Italy
JPET Fast Forward. Published on February 10, 2006 as DOI:10.1124/jpet.105.098350
Copyright 2006 by the American Society for Pharmacology and Experimental Therapeutics.
This article has not been copyedited and formatted. The final version may differ from this version.JPET Fast Forward. Published on February 10, 2006 as DOI: 10.1124/jpet.105.098350
at ASPE
T Journals on February 19, 2021
jpet.aspetjournals.orgD
ownloaded from
JPET #98350
2
Running Title: COX isoforms and colonic motility
Corresponding Author:
Prof. Corrado Blandizzi, M.D.
Divisione di Farmacologia e Chemioterapia, Dipartimento di Medicina Interna
Università di Pisa
Via Roma, 55, 56126 Pisa, Italy
Tel.: +39-050-830148; Fax: +39-050-562020; e-mail: [email protected]
Number of text pages: 27
Number of tables: 1
Number of figures: 7
Number of references: 28
Number of words in the abstract: 250
Number of words in the introduction: 498
Number of words in the discussion: 1028
Abbreviations: COX, cyclooxygenase; DAB, 3,3’-diaminobenzidine tetrahydrochloride;
DNBS, 2,4-dinitrobenzenesulfonic acid; dNTP, deoxynucleotide triphosphate; L-NAME, Nω-
nitro-L-arginine methylester; NO, nitric oxide; NOS, nitric oxide synthase; iNOS, inducible
nitric oxide synthase; PBS, phosphate buffered saline; ROS, reactive oxygen species; RT-
PCR, reverse transcription-polymerase chain reaction; SEM, standard error of mean; SMT, S-
methylisothiourea; SOD, superoxide dismutase; TES, transmural electrical stimulation.
Recommended section assignment: Gastrointestinal, Hepatic, Pulmonary, and Renal
This article has not been copyedited and formatted. The final version may differ from this version.JPET Fast Forward. Published on February 10, 2006 as DOI: 10.1124/jpet.105.098350
at ASPE
T Journals on February 19, 2021
jpet.aspetjournals.orgD
ownloaded from
JPET #98350
3
ABSTRACT
This study examines the role played by cyclooxygenase isoforms (COX-1 and COX-2) in the
regulation of colonic neuromuscular function in normal rats and after induction of colitis by
2,4-dinitrobenzenesulfonic acid (DNBS). The expression of COX-1 and COX-2 in the colonic
neuromuscular layer was assessed by RT-PCR and immunohistochemistry. The effects of
COX inhibitors on in vitro motility were evaluated by studying electrically induced and
carbachol-induced contractions of the longitudinal muscle. Both COX isoforms were
constitutively expressed in normal colon; COX-2 was upregulated in the presence of colitis.
In normal and inflamed colon, both COX isoforms were mainly localized in neurones of
myenteric ganglia. In the normal colon, indomethacin (COX-1/COX-2 inhibitor), SC-560
(COX-1 inhibitor) or DFU (COX-2 inhibitor) enhanced atropine-sensitive electrically evoked
contractions. The most prominent effects were observed with indomethacin or SC-560 plus
DFU. In the inflamed colon, SC-560 lost its effect, whereas indomethacin and DFU
maintained their enhancing actions. These results were more evident after blockade of non-
cholinergic pathways. In rats with colitis, in vivo treatment with superoxide dismutase or S-
methylisothiourea (inhibitor of inducible nitric oxide synthase) restored the enhancing motor
effect of SC-560. COX inhibitors had no effect on carbachol-induced contractions in normal
or DNBS-treated rats. In conclusion, in the normal colon both COX isoforms act at neuronal
level to modulate the contractile activity driven by excitatory cholinergic pathways. In the
presence of inflammation, COX-1 activity is hampered by oxidative stress, and COX-2 seems
to play a predominant role in maintaining an inhibitory control of colonic neuromuscular
function.
This article has not been copyedited and formatted. The final version may differ from this version.JPET Fast Forward. Published on February 10, 2006 as DOI: 10.1124/jpet.105.098350
at ASPE
T Journals on February 19, 2021
jpet.aspetjournals.orgD
ownloaded from
JPET #98350
4
Introduction
Since the discovery of two cyclooxygenase (COX) isoforms (COX-1, COX-2), efforts
have been made to examine the distribution and functional roles played by these enzymes in
the gastrointestinal tract. The mucosal layer of normal gut expresses high levels of COX-1
and low levels of COX-2 (Fornai et al., 2005a; Wallace and Devchand, 2005), whereas in the
presence of ulcer, inflammatory or neoplastic diseases, COX-2 expression can be upregulated.
In these settings, COX isoforms may play differential pathophysiological roles, such as the
involvement of COX-1 and COX-2 in the development of gastrointestinal damage induced by
non-steroidal anti-inflammatory drugs (NSAIDs) (Tanaka et al., 2002), and the carcinogenesis
and tumour cell proliferation promoted by COX-2-derived prostanoids (Subbaramaiah and
Dannenberg, 2003). By contrast, the pattern of COX isoform expression in gut neuromuscular
layers remains to be clarified. Previous reports described a significant COX-2 expression in
colonic myenteric plexus and myocytes of various species, including humans, under normal
conditions (Porcher et al., 2004; Fornai et al., 2005b), whereas other authors reported a scarce
or absent expression (Roberts et al., 2001; Schwarz et al., 2001).
Intestinal inflammation is associated with alterations of gut motility and may contribute
to the development of digestive symptoms (Collins, 1996). The mechanisms underlying
dysmotility are still uncertain, but altered functions of myenteric nerves and smooth muscle
have been observed (Sharkey and Kroese, 2001). Previous studies reported that COX
pathways are involved in the modulation of normal gastrointestinal motility (Porcher et al.,
2002; Porcher et al., 2004; Fornai et al., 2005b), and that in the presence of intestinal
inflammatory reactions COX-2 might contribute to the pathophysiology of related motor
alterations (Schwarz et al., 2001; Linden et al., 2004). For instance, experimental ileus in rats,
evoked by intestinal manipulation, was associated with enteric COX-2 induction, and
This article has not been copyedited and formatted. The final version may differ from this version.JPET Fast Forward. Published on February 10, 2006 as DOI: 10.1124/jpet.105.098350
at ASPE
T Journals on February 19, 2021
jpet.aspetjournals.orgD
ownloaded from
JPET #98350
5
treatments with selective COX-2 inhibitors significantly improved the intestinal contractile
activity, both in vivo and in vitro (Schwarz et al., 2001). Moreover, experimental colitis
induced by trinitrobenzenesulfonic acid in guinea-pigs is characterized by increased COX-2
expression in the colonic wall, and the products of this enzyme seem to be responsible for an
enhanced excitability of myenteric AH neurones. In this model, the inhibition of COX-2, but
not COX-1, restored the normal electrical properties of AH neurones, whereas the application
of prostaglandin E2 to inflamed colonic preparations decreased the afterhyperpolarization of
AH neurones and slowed their accommodation rate (Manning et al., 2002; Linden et al.,
2004). However, there is still uncertainty on the role of COX isoforms in motor alterations
associated with chronic intestinal inflammation and on the hypothesis that COX-derived
mediators may regulate differently gut motility under physiological or pathological conditions
(Costa, 2004).
The present study was designed to compare the role of COX isoforms in the control of
neuromuscular functions in normal rats and after the induction of colitis. For this purpose, we
examined the expression and localization of COX-1 and COX-2 in the colonic neuromuscular
layer, and the effects of COX blockade on in vitro colonic motor activity, using selective and
non-selective COX-inhibitors.
This article has not been copyedited and formatted. The final version may differ from this version.JPET Fast Forward. Published on February 10, 2006 as DOI: 10.1124/jpet.105.098350
at ASPE
T Journals on February 19, 2021
jpet.aspetjournals.orgD
ownloaded from
JPET #98350
6
Methods
Animals
Albino male Sprague-Dawley rats, 200-250 g body weight, were used throughout the
study. They were housed in temperature-controlled rooms, in a 12-h light-dark cycle at 22-24
°C and 50-60% humidity. Their care and handling were in accordance with the provision of
the European Union Council Directive 86/609, recognized and adopted by the Italian
Government.
Induction and assessment of colitis
Colitis was induced in accordance with the method previously described by Barbara et
al. (2000). Briefly, during anaesthesia with diethyl ether, 30 mg of 2,4-
dinitrobenzenesulphonic acid (DNBS) in 0.25 ml of 50% ethanol were administered
intrarectally via a polyethylene PE-60 catheter inserted 8 cm proximal to the anus. Control
rats received 0.25 ml of saline. Animals underwent subsequent experimental procedures 6
days after DNBS administration, to allow a full development of histologically evident colonic
inflammation. At that time, the animals were euthanized, and the severity of intestinal
inflammation was evaluated macroscopically and histologically in accordance with the
criteria previously reported by Wallace & Keenan (1990), as modified by Barbara et al.
(2000). The macroscopic criteria were based on the following: presence of adhesions between
colon and other intra-abdominal organs; consistency of colonic faecal material (indirect
marker of diarrhoea); thickening of colonic wall; presence and extension of hyperaemia and
macroscopic mucosal damage (assessed with the aid of a ruler). Microscopic criteria were
assessed by light microscopy on haematoxylin- and eosin-stained sections obtained from
whole-gut specimens, taken from a region of inflamed colon immediately adjacent to the
gross macroscopic damage and fixed in cold 4% neutral formalin diluted in phosphate
buffered saline (PBS). Histological criteria included: degree of mucosal architecture changes;
This article has not been copyedited and formatted. The final version may differ from this version.JPET Fast Forward. Published on February 10, 2006 as DOI: 10.1124/jpet.105.098350
at ASPE
T Journals on February 19, 2021
jpet.aspetjournals.orgD
ownloaded from
JPET #98350
7
cellular infiltration; external muscle thickening; presence of crypt abscess and goblet cell
depletion. All parameters of macroscopic and histological damage were recorded and scored
for each rat by two observers blinded to the treatment.
Reverse transcription-polymerase chain reaction
Expression of mRNA coding for COX isoforms was assessed by reverse transcription-
polymerase chain reaction (RT-PCR). The analysis was performed on colonic specimens
excised as reported above, subjected to mucosa and submucosa removal, snap-frozen in liquid
nitrogen, and stored at -80°C. At the time of extraction, tissue samples were disrupted with
cold glass pestles and total RNA was isolated by Trizol (Life Technologies, Carlsbad, CA,
U.S.A.) and chloroform. Total RNA (1 µg) served as template for cDNA synthesis in a
reaction using 2 µl random hexamers (0.5 µg/µl) with 200 U of MMLV-reverse transcriptase
in a buffer containing 500 µM deoxynucleotide triphosphate mixture (dNTP) and 10 mM
dithiothreitol. cDNA samples were subjected to PCR in the presence of primers based on
cloned rat COX isoforms (Tanaka et al., 2002). PCR, consisting of 5 µl of RT products, Taq
polymerase 2.5 U, dNTP 100 µM and primers 0.5 µM, was carried out by a PCR-Express
thermocycler (Hybaid, Ashford, Middlesex, U.K.). After 3 min at 94°C, the cycle conditions
were 1 min at 94°C, 1 min at 55°C and 1 min at 72°C for 30 cycles, followed by 7 min at
72°C. Aliquots of RNA not subjected to RT were included in PCR reactions to verify the
absence of genomic DNA. The efficiency of RNA extraction, RT and PCR was evaluated by
primers for rat β-actin. PCR products were separated by 1.8% agarose gel electrophoresis in a
Tris buffer 40 mM containing 2 mM ethylenediamine tetraacetic acid, 20 mM acetic acid (pH
8), and stained with ethidium bromide. PCR products were then visualized by UV light and
subjected to densitometric analysis by Kodak Image Station program (Eastman Kodak Co.,
Rochester, NY, U.S.A.). The relative expression of target mRNA was normalized to that of β-
actin.
This article has not been copyedited and formatted. The final version may differ from this version.JPET Fast Forward. Published on February 10, 2006 as DOI: 10.1124/jpet.105.098350
at ASPE
T Journals on February 19, 2021
jpet.aspetjournals.orgD
ownloaded from
JPET #98350
8
Immunohistochemical analysis
Specimens of colonic tissue, excised and fixed as reported above, were dehydrated with
ethanol, treated with xylene and embedded in paraffin at 56°C. Serial sections (5-µm-thick)
were processed for immunostaining: slides were treated with 1% hydrogen peroxide in
methanol, microwaved in citrate buffer, and blocked with normal swine serum (1:20;
Dakopatts, Glostrup, Denmark). Sections were then incubated overnight at 4°C with the
following polyclonal primary antibodies: rabbit anti-COX-1 (1:200; Cayman Chemical
Company, code no. 160109, Ann Arbor, Michigan, U.S.A.); rabbit anti-COX-2 (1:3000;
Alexis Biochemicals, code no. ALX 210711, Lausen, Switzerland); rabbit anti-neurofilament
(1:4000; Chemicon, code no. AB 1987, Temecula, California, U.S.A.). Immunoglobulins
were diluted in PBS with 0.1% bovine serum albumin and 0.1% sodium azide. Sections were
washed with PBS and incubated with biotinylated immunoglobulins followed by peroxidase-
labeled streptavidin complex and 3,3’-diaminobenzidine tetrahydrochloride (DAB;
Dakopatts, Glostrup, Denmark) (Bernardini et al., 1999). Sections were counterstained with
haematoxylin. All reactions were carried out at room temperature in a humidified chamber
and PBS was used for washes, unless otherwise specified. Negative controls were obtained by
omitting primary antibodies or substituting the primary antibody with rabbit preimmune
serum. Specificity of COX immunoreacting staining was assessed by pre-adsorbing anti-
COX-1 and -COX-2 antibodies with COX-1 (Cayman Chemical Company, cod. no. CAY
360109) and COX-2 (Alexis Biochemicals, cod. no. ALX 153-063) blocking peptides,
respectively, at ten times the antibody concentrations for 24 h at 4°C. To test endogenous
peroxidases and avidin-binding activity, slides were incubated only with DAB or streptavidin-
peroxidase complex plus DAB, respectively.
This article has not been copyedited and formatted. The final version may differ from this version.JPET Fast Forward. Published on February 10, 2006 as DOI: 10.1124/jpet.105.098350
at ASPE
T Journals on February 19, 2021
jpet.aspetjournals.orgD
ownloaded from
JPET #98350
9
Recording of longitudinal muscle contractile activity
The contractile activity of colonic longitudinal smooth muscle was recorded as
previously described by Blandizzi et al. (2003). Specimens of colon, excised as reported
above, were placed into cold pre-oxygenated Krebs solution, opened along the mesenteric
insertion and subjected to removal of mucosal/submucosal layer. The specimens were then
cut along the longitudinal axis into strips of approximately 3 mm width and 20 mm length.
The preparations were set up in 10-ml organ baths containing Krebs solution at 37°C, bubbled
with 95% O2+5% CO2, connected to isotonic transducers (Basile, Comerio, Italy) under a
constant load of 1 g, and allowed to equilibrate for 30 min. Since there was no need to
discriminate between active and passive tension developed by intestinal muscle, isotonic
transducers were used to estimate changes in smooth muscle elongation under constant
tension in response to stimulation. Krebs solution had the following composition (mM): NaCl
113, KCl 4.7, CaCl2 2.5, KH2PO4 1.2, MgSO4 1.2, NaHCO3 25, glucose 11.5 (pH 7.4±0.1).
The contractile activity was recorded by a polygraph (Basile, Comerio, Italy). A pair of
coaxial platinum electrodes was positioned at distance of 10 mm from longitudinal axis of
each preparation to deliver transmural electrical stimulation (TES) by a BM-ST6 stimulator
(Biomedica Mangoni, Pisa, Italy). Stimuli were applied as 10-s single trains of square wave
pulses (0.5 ms, 30 mA, 10 Hz). Each preparation was repeatedly challenged with electrical
stimulations, and experiments started when reproducible responses were obtained (usually
after 2-3 stimulations).
In the first set of experiments, colonic preparations were exposed to indomethacin
(COX-1/COX-2 inhibitor, 1 µM), SC-560 (COX-1 inhibitor, 0.1 µM) or DFU (COX-2
inhibitor, 1 µM), for 30 min before TES. Preparations were incubated with test drugs along
two 15-min consecutive periods with an intervening washing. Drug concentrations were
selected on the basis of previous studies (Riendeau et al., 1997; Kato et al., 2001).
This article has not been copyedited and formatted. The final version may differ from this version.JPET Fast Forward. Published on February 10, 2006 as DOI: 10.1124/jpet.105.098350
at ASPE
T Journals on February 19, 2021
jpet.aspetjournals.orgD
ownloaded from
JPET #98350
10
The second set of experiments was designed to assay COX inhibitors on contractile
responses elicited by TES directed to cholinergic innervation. For this purpose, colonic
preparations were maintained in Krebs solution containing guanethidine (adrenergic blocker,
10 µM), Nω-nitro-L-arginine methylester (L-NAME, inhibitor of nitric oxide synthase, NOS,
100 µM), L-732,138 (NK1 receptor antagonist, 10 µM), GR-159897 (NK2 receptor antagonist,
1 µM) and SB-218795 (NK3 receptor antagonist, 1 µM), to prevent non-cholinergic motor
responses (Fornai et al., 2005b). Incubation of colonic strips with COX inhibitors before
challenge with TES was performed as reported above.
In the third series, COX inhibitors were assayed on cholinergic contractions elicited by
direct pharmacological activation of muscarinic receptors on smooth muscle cells.
Preparations were maintained in Krebs solution containing tetrodotoxin (1 µM), and
stimulated twice with carbachol (muscarinic receptor agonist, 1 µM). The first stimulation
was applied in the absence of other drugs, while the second one was applied after 30-min
incubation with COX inhibitors, as reported above.
In a fourth set of experiments, the effects of COX inhibitors on TES-evoked motor
responses were assessed on colonic preparations obtained from control or DNBS-treated rats
treated daily with superoxide dismutase (SOD, 7 mg/kg/day s.c.) (Segui et al., 2004) or S-
methylisothiourea (SMT, 14 mg/kg/day s.c.), a selective inhibitor of inducible NOS (iNOS)
(Afulukwe et al., 2000), for 6 consecutive days starting 1 h before the induction of colitis.
Drugs and reagents
Indomethacin, SC-560 ([5-(4-clorophenyl)-1-(4-metoxyphenyl)-3-trifluoromethyl-
pirazole), atropine sulphate, hexamethonium bromide, Nω-nitro-L-arginine methylester,
carbachol hydrochloride, guanethidine, superoxide dismutase, S-methylisothiourea (Sigma
Chemical, St. Louis, MO, U.S.A.); DFU [3-(3-fluorophenyl)-4-(4-methanesulfonyl)-5,5-
dimethyl-5H-furan-2-one] (kindly provided by Merck Research Laboratories, Rahway, NJ,
This article has not been copyedited and formatted. The final version may differ from this version.JPET Fast Forward. Published on February 10, 2006 as DOI: 10.1124/jpet.105.098350
at ASPE
T Journals on February 19, 2021
jpet.aspetjournals.orgD
ownloaded from
JPET #98350
11
U.S.A.); L-732,138 (N-acetyl-L-tryptophan 3,5-bis(trifluoromethyl)benzyl ester), GR-159897
(5-fluoro-3-[2-[4-methoxy-4-[[(R)-phenylsulphinyl]methyl]-1-piperidinyl]ethyl]-1H-indole),
SB-218795 ((R)-[[2-phenyl-4-quinolinyl)carbonyl]amino]-methyl ester benzeneacetic acid),
tetrodotoxin (Tocris Cookson, Bristol, U.K.); random hexamers, MMLV-reverse
transcriptase, Taq polymerase, dNTP mixture (Promega, Madison, WI, U.S.A.). COX
inhibitors were dissolved in dimethylsulphoxide and further dilutions were made with saline
solution. Dimethylsulphoxide concentration in organ bath never exceeded 0.5%.
Statistical analysis
Results are given as mean standard ± error of mean (SEM). The significance of
differences was evaluated on raw data, prior to percentage normalization, by Student t test for
unpaired data or one way analysis of variance followed by post hoc analysis with Student-
Newman-Keuls test, and P<0.05 was considered significant. Colonic preparations included in
each test group were obtained from distinct animals, and therefore the number of experiments
refers also to the number of animals assigned to each group. Calculations were performed by
commercial software (GraphPad Prism™, version 3.0 from GraphPad Software Inc., San
Diego, CA, U.S.A.).
This article has not been copyedited and formatted. The final version may differ from this version.JPET Fast Forward. Published on February 10, 2006 as DOI: 10.1124/jpet.105.098350
at ASPE
T Journals on February 19, 2021
jpet.aspetjournals.orgD
ownloaded from
JPET #98350
12
Results
Assessment of colitis
Six days after DNBS treatment, the distal colon appeared thickened and ulcerated with
evident areas of transmural inflammation. Adhesions were often present and the bowel was
occasionally dilated. Histologically, colitis was evident as granulocyte infiltration extending
throughout the mucosa and submucosa, sometimes involving the muscular layer. More than
five-fold increase in both macroscopic and microscopic damage score was estimated in
DNBS-treated animals in comparison with normal rats. In rats with colitis, treated with SOD
or SMT, both macroscopic and microscopic damage scores were significantly decreased,
although being still significantly greater than normal values (Table 1).
RT-PCR analysis
RT-PCR analysis revealed the expression of COX-1 and COX-2 in colonic
neuromuscular layers of both normal and DNBS-treated animals (Figure 1A). The
densitometric analysis, performed on amplified cDNA bands, indicated a significant increase
in the expression of COX-2 mRNA in the presence of colitis (Figure 1C), whereas no
appreciable changes in the expression of COX-1 were detected (Figure 1B).
Immunohistochemical analysis
Both COX-1 and COX-2 are constitutively expressed in the tunica muscularis of normal
rat colon (Figure 2A and C). In particular, COX-1 was found in neurons and glial cells of
myenteric ganglia as well as in few cells of muscular layer (Figure 2A and 3A), whereas little
COX-2 immunoreactivity was expressed only in myenteric neurons (Figure 2C and 3C).
Colonic neuromuscular tissues from animals with colitis showed different patterns of COX
isoform expression (Figure 2B, D and 3B, D) compared to normal rats. Myenteric ganglionic
cells and few smooth muscle cells expressed detectable amount of COX-1 (Figure 2B and
3B), which was similar to normal colonic tissues. By contrast, high COX-2 expression was
This article has not been copyedited and formatted. The final version may differ from this version.JPET Fast Forward. Published on February 10, 2006 as DOI: 10.1124/jpet.105.098350
at ASPE
T Journals on February 19, 2021
jpet.aspetjournals.orgD
ownloaded from
JPET #98350
13
found in the neuromuscular compartment of colonic specimens excised from animals with
colitis: intense COX-2 immunoreactivity was detected in myenteric ganglionic cells and
muscular layers (Figure 2D and 3D). In the latter case, COX-2 was mainly localized at level
of longitudinal muscle cell nuclei (Figure 2D), in accordance with previously reported COX-2
nuclear labelling (Maihofner et al., 2000). Neurones of myenteric ganglia were localized by
means of immunoreactivity to neurofilament both in normal (Figure 2E) and inflamed colon
(Figure 2F). Pre-adsorption of primary antibodies with the respective blocking peptides
completely abolished any specific immunoreactivity (data not shown).
Effects of COX inhibitors on longitudinal smooth muscle activity
During the equilibration period, most colonic preparations, obtained from normal or
DNBS-treated rats, showed rapid and low in amplitude spontaneous activity, which remained
stable throughout the experiment. TES-induced responses consisted of fast phasic
contractions often followed by aftercontractions of variable amplitude (Figure 4). The use of
isotonic transducers allowed to record electrically-evoked contractions as changes in smooth
muscle elongation under constant tension, thus minimizing possible inflammation-induced
variations of intrinsic contractile activity. Accordingly, control responses of normal tissues
did not differ significantly from those observed in colonic preparations from DNBS-treated
rats. Pre-incubation with atropine (1 µM) inhibited phasic contractions, or converted them
into relaxations, and only aftercontractions were evident. Tetrodotoxin (1 µM) abolished the
contractile responses evoked by TES (not shown).
Incubation of colonic preparations from normal or DNBS-treated animals with
indomethacin, SC-560 or DFU was not associated with significant changes in spontaneous
motor activity. In normal colonic tissues, indomethacin significantly enhanced contractions
evoked by TES (+64%, 1 µM) (Figure 4 and 5A). SC-560 (0.1 µM) or DFU (1 µM) mimicked
this enhancing action, but they were less effective than indomethacin (+41% and +36%)
This article has not been copyedited and formatted. The final version may differ from this version.JPET Fast Forward. Published on February 10, 2006 as DOI: 10.1124/jpet.105.098350
at ASPE
T Journals on February 19, 2021
jpet.aspetjournals.orgD
ownloaded from
JPET #98350
14
(Figure 4 and 5A). After combined incubation with SC-560 plus DFU, TES elicited
contractile responses with amplitude (+61%) comparable to that observed with indomethacin
(Figure 5A). In colonic preparations from rats with colitis, indomethacin (1 µM) or DFU (1
µM) evoked significant and similar increments of TES-induced contractions (+32% and
+34%, respectively) (Figure 4 and 5B), whereas SC-560 (0.1 µM) was without effect (Figure
4 and 5B). After co-incubation of colonic tissues with SC-560 plus DFU the enhancement of
TES-induced contractions was similar to that observed in the presence of indomethacin or
DFU alone (+39%) (Figure 5B).
In the presence of guanethidine, L-NAME and NK receptor antagonists, TES evoked
contractions of colonic preparations, obtained from normal or DNBS-treated rats, which were
completely prevented, or markedly reduced, by atropine (1 µM, not shown). Under these
conditions, TES-induced motor responses were suppressed by tetrodotoxin (1 µM) and
unaffected by hexamethonium (10 µM). In normal preparations, indomethacin (1 µM)
significantly enhanced cholinergic responses elicited by TES (+94%) (Figure 5C). SC-560
(0.1 µM) or DFU (1 µM) mimicked this excitatory effect, although they were less effective
(+58% and +61%) (Figure 5C). Incubation with SC-560 plus DFU was followed by a
potentiation of TES-induced contractions (+97%) similar to that achieved with indomethacin
alone (Figure 5C). In colonic tissues isolated from rats with colitis, indomethacin (1 µM) or
DFU (1 µM) significantly increased TES-induced contractions, and acted with similar
efficacy (+55% and +49%, respectively), whereas SC-560 (0.1 µM) did not exert any
significant effect (Figure 5D). Following co-incubation of colonic tissues with SC-560 plus
DFU, TES-evoked contractions were enhanced to a similar extent to that observed with
indomethacin or DFU alone (+64%) (Figure 5D).
This article has not been copyedited and formatted. The final version may differ from this version.JPET Fast Forward. Published on February 10, 2006 as DOI: 10.1124/jpet.105.098350
at ASPE
T Journals on February 19, 2021
jpet.aspetjournals.orgD
ownloaded from
JPET #98350
15
Exposure of colonic preparations, from normal or DNBS-treated animals, to carbachol
(1 µM) resulted in phasic contractions (Figure 6) sensitive to atropine. Under these
conditions, carbachol-induced responses were not affected by indomethacin (1 µM) either in
the absence or in the presence of colitis (Figure 6). Analogously, SC-560 (0.1 µM), DFU (1
µM) or SC-560 plus DFU did not modify the motor responses elicited by carbachol (Figure
6).
When colonic preparations, isolated from animals treated with DNBS plus SOD, were
exposed to indomethacin (1 µM), the contractile responses evoked by TES were significantly
increased (+66%) (Figure 7A). Under these conditions, SC-560 (0.1 µM) or DFU (1 µM)
significantly enhanced TES-evoked motor activity, although they were less effective than
indomethacin (+28% and +46%, respectively) (Figure 7A). Co-incubation of colonic tissues
with SC-560 plus DFU resulted in increments of TES-induced contractions similar to those
observed in the presence of indomethacin alone (+69%) (Figure 7A). In colonic tissues from
rats with colitis subjected to in vivo iNOS blockade by SMT, COX inhibitors enhanced TES-
induced contractions, with response patterns similar to those recorded after treatment of
animals with DNBS plus SOD (Figure 7B). Incubation of colonic tissues, obtained from
normal rats treated with SOD or SMT, with COX inhibitors, resulted in enhancements of
TES-induced contractions which did not differ significantly from those observed in the
absence of SOD or SMT.
This article has not been copyedited and formatted. The final version may differ from this version.JPET Fast Forward. Published on February 10, 2006 as DOI: 10.1124/jpet.105.098350
at ASPE
T Journals on February 19, 2021
jpet.aspetjournals.orgD
ownloaded from
JPET #98350
16
Discussion
This study provides evidence that: 1) both COX isoforms are constitutively expressed in
colonic neuromuscular layers in the rat and contribute to the modulation of cholinergic motor
activity acting at neuronal level; 2) in the presence of colitis, the COX-2 isoform plays a
predominant role in this regulatory function.
Our molecular and morphological analysis clearly demonstrated expression of both
COX-1 and COX-2 in the neuromuscular layer of normal rat colon and up-regulation of
COX-2 expression in the inflamed colon. In particular, immunohistochemistry indicated a
predominant localization of both COX isoforms in neurons of myenteric ganglia and an
increased immunostaining of COX-2 at the same sites in the presence of colitis. These
findings add evidence to the concept that COX-2 can be expressed constitutively in the
normal gut (as we and others have previously reported in human and mouse gut; Fornai et al.,
2005b; Porcher et al., 2002; Porcher et al., 2004) and could play a role in the control of
myenteric nerve function during intestinal inflammation. In addition, Roberts et al. (2001)
demonstrated increased COX-2 immunoreactivity in colonic myenteric neurons of patients
with ulcerative colitis or Crohn’s disease, and Schwarz et al. (2001) found enhancement of
COX-2 immunostaining in neurones and smooth muscle cells from jejunal tissues of rats
undergoing intestinal manipulation (an experimental model of postoperative ileus).
The pharmacological blockade of COX isoforms in normal colonic preparations
significantly increased electrically induced contractions, especially after pharmacological
ablation of non-cholinergic nerve pathways. Electrically evoked cholinergic contractions were
enhanced after exposure to either SC-560 (COX-1 inhibitor) or DFU (COX-2 inhibitor). Even
more pronounced effects (of similar magnitude) were recorded with the non selective
inhibitor indomethacin and with combined blockade of both COX isoforms by SC-560 plus
DFU.
This article has not been copyedited and formatted. The final version may differ from this version.JPET Fast Forward. Published on February 10, 2006 as DOI: 10.1124/jpet.105.098350
at ASPE
T Journals on February 19, 2021
jpet.aspetjournals.orgD
ownloaded from
JPET #98350
17
The present findings strengthen the notion that COX-derived products can modulate
enteric cholinergic neurotransmission in the normal gut. De Backer et al. (2003) reported that
indomethacin enhances the electrically induced acetylcholine release in muscle strips of pig
stomach, suggesting inhibition by prostanoids of intramural cholinergic neurones.
Furthermore, we previously observed that selective and non selective COX inhibitors
potentiate electrically induced cholinergic contractions of smooth muscle strips prepared from
human distal colon (Fornai et al., 2005b). In contrast with findings in humans, pigs and rats,
experiments performed on guinea-pig intestine indicated that the electrically or nicotine-
induced acetylcholine release and related cholinergic contractions are enhanced by application
of exogenous prostaglandins and inhibited by indomethacin, suggesting that in this species
endogenous prostanoids mediate excitation of cholinergic enteric pathways (Takeuchi et al.,
1991). Therefore, the effects of prostanoids and COX inhibitors on gut motility depend on
species, gut region and muscular layer.
Our observation that TES-, but not carbachol-induced contractions were affected by
COX-blockade indicates that the modulating control of COX pathways on cholinergic motor
activity occurs at neuronal rather than at muscular sites. These functional data are consistent
with our molecular analysis showing that both COX-1 and COX-2 were detected
predominantly in neurones of myenteric ganglia, with no appreciable immunostaining in the
muscular layers. Thus, it is conceivable that prostanoids produced by COX-1 and COX-2,
both located in myenteric neurones, inhibit colonic cholinergic neurotransmission. In line
with this proposal, preliminary in vivo experiments performed in our laboratory indicated that
colonic transit in normal animals was enhanced by either COX-1 or COX-2 blockade,
whereas COX-1 inhibition was without effects in rats with colitis (Del Tacca et al.,
unpublished data).
This article has not been copyedited and formatted. The final version may differ from this version.JPET Fast Forward. Published on February 10, 2006 as DOI: 10.1124/jpet.105.098350
at ASPE
T Journals on February 19, 2021
jpet.aspetjournals.orgD
ownloaded from
JPET #98350
18
In colonic preparations obtained from rats with colitis, SC-560 lost its enhancing effect
on electrically induced cholinergic contractions, whereas increments of similar degree were
observed upon application of indomethacin, DFU or indomethacin plus DFU. The modulating
function of COX-2 was likely to occur still at neuronal level, as neither indomethacin nor
DFU affected carbachol-induced contractions.
An intriguing finding in rats with colitis is that the functional data are not fully
consistent with the patterns of COX isoform localization: while expression of COX-2
increased, the motor enhancing effects resulting from its pharmacological inhibition remained
nearly unchanged. On the other hand, COX-1 expression did not vary, but its blockade was
without effects on the evoked cholinergic contractions. To get further insight into this aspect,
it is noteworthy that gut inflammation is associated with increased production of reactive
oxygen species (ROS), such as superoxide anion radicals (O2-) and peroxynitrite anions
(ONOO-), known to induce oxidative tissue injury (Dijkstra et al., 1998), and that
peroxynitrite anions, generated from the reaction between nitric oxide (NO) and superoxide
anions, can downregulate the catalytic activities of COX enzymes, especially COX-1
(Fujimoto et al., 2004). Accordingly, antioxidants were reported to ameliorate experimental
colitis (Segui et al., 2004; Oz et al., 2005). Thus, it is conceivable that, in the presence of
colitis, increased production of peroxynitrite anions could functionally inactivate COX-1
activity, whereas COX-2 overexpression could remain functionally silent because of the
inhibition exerted by reactive oxygen species. To test this hypothesis, we performed
functional experiments on colonic preparations obtained from rats with colitis treated with
SOD (the enzyme responsible for O2- inactivation) or SMT (a selective inhibitor of iNOS, the
main source of NO in inflamed tissues). Evidence was thus obtained that the in vivo
antioxidant treatment with SOD or SMT could prevent COX-1 inactivation. Indeed, under
This article has not been copyedited and formatted. The final version may differ from this version.JPET Fast Forward. Published on February 10, 2006 as DOI: 10.1124/jpet.105.098350
at ASPE
T Journals on February 19, 2021
jpet.aspetjournals.orgD
ownloaded from
JPET #98350
19
these conditions, SC-560 almost completely recovered its ability to enhance the electrically
evoked contractions of colonic longitudinal muscle strips.
Taking together our molecular and pharmacological findings, it appears that, in the
presence of inflammation, changes in the control of colonic motility by COX pathways reflect
mainly impaired function of these enzymes because of increased oxidative stress. Thus, as
postulated by Costa (2004), COX-derived mediators do not seem to play distinct
physiological and pathological roles, at least in the case of gut motility, and the induction of
COX-2 expression by intestinal inflammation might be viewed as an attempt of endogenous
homeostatic mechanisms to preserve or restore the modulating actions of COX products.
In conclusion, this study indicates that both COX-1 and COX-2 are constitutively
expressed in the neuromuscular layer of normal rat colon, where they are mainly localized in
neurones of myenteric ganglia and contribute to inhibition of excitatory cholinergic pathways.
In the presence of colitis, the COX-2 isoform seems to play a predominant role in driving this
modulating action.
This article has not been copyedited and formatted. The final version may differ from this version.JPET Fast Forward. Published on February 10, 2006 as DOI: 10.1124/jpet.105.098350
at ASPE
T Journals on February 19, 2021
jpet.aspetjournals.orgD
ownloaded from
JPET #98350
20
References
Afulukwe IF, Cohen RI, Zeballos GA, Iqbal M and Scharf SM (2000) Selective NOS
inhibition restores myocardial contractility in endotoxemic rats: however, myocardial
NO content does not correlate with myocardial dysfunction. Am J Respir Crit Care Med
162:21-26.
Barbara G, Xing Z, Hogaboam CM, Gauldie J and Collins SM (2000) Interleukin 10 gene
transfer prevents experimental colitis in rats. Gut 46:344-349.
Bernardini N, Bianchi F and Dolfi A (1999) Laminin and beta1 integrin distribution in the
early stages of human kidney development. Nephron 81:289-295.
Blandizzi C, Fornai M, Colucci R, Baschiera F, Barbara G, De Giorgio R, De Ponti F, Breschi
MC and Del Tacca M (2003) Altered prejunctional modulation of intestinal cholinergic
and noradrenergic pathways by α2-adrenoceptors in the presence of experimental colitis.
Br J Pharmacol 139:309-320.
Collins SM (1996) The immunomodulation of enteric neuromuscular function: implications
for motility and inflammatory disorders. Gastroenterology 111:1683-1699.
Costa M (2004) COX and the gut: now we see it now we don’t. Neurogastroenterol Motil
16:693-695.
De Backer O, Leclere PG and Lefebvre RA (2003) Pharmacological characterization of pre-
and postsynaptic prostanoid receptors in pig gastric fundus. Neuropharmacology
45:684-690.
Dijkstra G, Moshage H, Van Dullemen HM, De Jager-Krikken A, Tiebosch ATMG,
Kleibeuker JH, Jansen PLM and Van Goor H (1998) Expression of nitric oxide synthase
and formation of nitrotyrosine and reactive oxygen species in inflammatory bowel
disease. J Pathol 186:416-421.
This article has not been copyedited and formatted. The final version may differ from this version.JPET Fast Forward. Published on February 10, 2006 as DOI: 10.1124/jpet.105.098350
at ASPE
T Journals on February 19, 2021
jpet.aspetjournals.orgD
ownloaded from
JPET #98350
21
Fornai M, Natale G, Colucci R, Tuccori M, Carazzina G, Antonioli L, Baldi S, Lubrano V,
Abramo A, Blandizzi C and Del Tacca M (2005a) Mechanisms of protection by
pantoprazole against NSAID-induced gastric mucosal damage. Naunyn Schmiedebergs
Arch Pharmacol 372:79-87.
Fornai M, Blandizzi C, Colucci R, Antonioli L, Bernardini N, Segnani C, Baragatti B, Barogi
S, Berti P, Spisni R and Del Tacca M (2005b) Role of cyclooxygenase 1 and 2 in the
modulation of neuromuscular functions in the distal colon of humans and mice. Gut
54:608-616.
Fujimoto Y, Uno E and Sakuma S (2004) Effects of reactive oxygen and nitrogen species on
cyclooxygenase-1 and -2 activities. Prostaglandins Leukot Essent Fatty Acids 71:335-
340.
Kato M, Nishida S, Kitasato H, Sakata N and Kawai S (2001) Cyclooxygenase-1 and
cyclooxygenase-2 selectivity of non-steroidal anti-inflammatory drugs: investigation
using human peripheral monocytes. J Pharm Pharmacol 53:1679-1685.
Linden DR, Sharkey KA, Ho W and Mawe GM (2004) Cyclooxygenase-2 contributes to
dysmotility and enhance excitability of myenteric AH neurones in the inflamed guinea
pig distal colon. J Physiol 557:191-205.
Maihofner C, Tegeder I, Euchenhofer C, Dewitt D, Brune K, Bang R, Neuhuber W and
Geisslinger G (2000) Localization and regulation of cyclo-oxygenase-1 and -2 and
neuronal nitric oxide synthase in mouse spinal cord. Neuroscience 101:1093-1108.
Manning BP, Sharkey KA, Mawe GM (2002) Effects of PGE2 in guinea pig colonic
myenteric ganglia. Am J Physiol 283:G1388-G1397.
Oz HS, Chen TS, McClain CJ and de Villiers WJS (2005) Antioxidants as novel therapy in a
murine model of colitis. J Nutrit Biochem 16:297-304.
This article has not been copyedited and formatted. The final version may differ from this version.JPET Fast Forward. Published on February 10, 2006 as DOI: 10.1124/jpet.105.098350
at ASPE
T Journals on February 19, 2021
jpet.aspetjournals.orgD
ownloaded from
JPET #98350
22
Porcher C, Horowitz B, Bayguinov O, Ward SM and Sanders KM (2002) Constitutive
expression and function of cyclooxygenase-2 in murine gastric muscle.
Gastroenterology 122:1442-1454.
Porcher C, Horowitz B, Ward SM and Sanders KM (2004) Constitutive expression and
functional expression of cyclooxygenase 2 in the murine proximal colon.
Neurogastroenterol Motil 16:785-799.
Riendeau D, Percival MD, Boyce S, Brideau C, Charleson S, Cromlish W, Ethier D, Evans J,
Falgueyret JP, Ford-Hutchinson AW, Gordon R, Greig G, Gresser M, Guay J, Kargman
S, Leger S, Mancini JA, O'Neill G, Ouellet M, Rodger IW, Therien M, Wang Z, Webb
JK, Wong E and Chan CC (1997) Biochemical and pharmacological profile of a
tetrasubstituted furanone as a highly selective COX-2 inhibitor. Br J Pharmacol
121:105-117.
Roberts PJ, Morgan K, Miller R, Hunter JO, Middleton SJ (2001) Neuronal COX-2
expression in human myenteric plexus in active inflammatory bowel disease. Gut
48:468-472.
Schwarz NT, Kalff JC, Turler A, Engel BM, Watkins SC, Billiar TR and Bauer AG (2001)
Prostanoid production via COX-2 as a causative mechanism of rodent postoperative
ileus. Gastroenterology 121:1354-1371.
Segui J, Gironella M, Sans M, Granell S, Gil F, Gimeno M, Coronel P, Pique JM and Panes J
(2004) Superoxide dismutase ameliorates TNBS-induced colitis by reducing oxidative
stress, adhesion molecule expression, and leukocyte recruitment into the inflamed
intestine. J Leukoc Biol 76:537-544.
Sharkey KA and Kroese ABA (2001) Consequences of intestinal inflammation on the enteric
nervous system: neuronal activation induced by inflammatory mediators. Anat Rec
262:79-90.
This article has not been copyedited and formatted. The final version may differ from this version.JPET Fast Forward. Published on February 10, 2006 as DOI: 10.1124/jpet.105.098350
at ASPE
T Journals on February 19, 2021
jpet.aspetjournals.orgD
ownloaded from
JPET #98350
23
Subbaramaiah K and Dannenberg AJ (2003) Cyclooxygenase 2: a molecular target for cancer
prevention and treatment. Trends Pharmacol Sci 24:96-102.
Takeuchi T, Okuda M and Yagasaki O (1991) The differential contribution of endogenous
prostaglandins to the release of acetylcholine from the myenteric plexus of the guinea-
pig ileum. Br J Pharmacol 102:381-385.
Tanaka A, Hase S, Miyazawa T and Takeuchi K (2002) Up-regulation of cyclooxygenase-2
by inhibition of cyclooxygenase-1: a key to nonsteroidal anti-inflammatory drug-
induced intestinal damage. J Pharmacol Exp Ther 300:754-761.
Wallace JL and Keenan CM (1990) An orally active inhibitor of leukotriene synthesis
accelerates healing in a rat model of colitis. Am J Physiol 258:G527-G534.
Wallace JL and Devchand PR (2005) Emerging roles for cyclooxygenase-2 in gastrointestinal
mucosa defense. Br J Pharmacol 145:275-282.
This article has not been copyedited and formatted. The final version may differ from this version.JPET Fast Forward. Published on February 10, 2006 as DOI: 10.1124/jpet.105.098350
at ASPE
T Journals on February 19, 2021
jpet.aspetjournals.orgD
ownloaded from
JPET #98350
24
Footnotes
The present work was supported by a grant from the Italian Ministry of Education, University
and Research (PRIN-COFIN 2002, Project number 2002052573-003).
This article has not been copyedited and formatted. The final version may differ from this version.JPET Fast Forward. Published on February 10, 2006 as DOI: 10.1124/jpet.105.098350
at ASPE
T Journals on February 19, 2021
jpet.aspetjournals.orgD
ownloaded from
JPET #98350
25
Figure legends
Figure 1. Reverse transcription-polymerase chain reaction analysis of COX-1, COX-2 and β-
actin mRNA in the muscular layer of distal colon obtained from rats under normal conditions
or with DNBS-induced colitis. (A) Three representative agarose gels, referring to the
amplification of COX-1, COX-2 and β-actin cDNAs. (B, C) Column graphs referring to the
densitometric analysis of COX-1 and COX-2 cDNAs bands normalised to the expression of
β-actin. Each column represents the mean value ± SEM obtained from 6 experiments.
*P<0.05: significant difference vs normal values.
Figure 2. Immunohistochemical detection of COX-1 (A, B), COX-2 (C, D) and
neurofilament (NFL; E, F) performed on adjacent sections of colon from rats under normal
conditions (A, C, E, G) or with DNBS-induced colitis (B, D, F, H). Circular (cm) and
longitudinal (lm) smooth muscle. Neurons of myenteric ganglia (arrowheads). (A) Normal
colonic neuromuscular tissue shows detectable amount of COX-1 in neurons (arrowheads)
and glial cells of myenteric ganglia as well as in few smooth muscle cells of circular and
longitudinal muscular layers. (B) Rats with colitis show no appreciable variation of COX-1
expression in colonic neuromuscular structures compared to normal rats. (C) COX-2 is
weakly expressed in myenteric neurons (arrowheads) of colon from normal animals. (D)
COX-2 staining is enhanced in colonic neuromuscular structures of rats with colitis: COX-2 is
strongly expressed both in myenteric ganglia (arrowheads) and tunica muscularis mainly at
level of longitudinal layer. (E, F) Neurons (arrowheads) are identified within myenteric
neurons of colon from normal (E) or DNBS-treated (F) rats by anti-neurofilament (NFL)
immunoreaction. (G, H) No specific immunoreaction is observed in serial sections of
specimens from normal (G) or DNBS-treated (H) animals, incubated with preimmune rabbit
serum.
This article has not been copyedited and formatted. The final version may differ from this version.JPET Fast Forward. Published on February 10, 2006 as DOI: 10.1124/jpet.105.098350
at ASPE
T Journals on February 19, 2021
jpet.aspetjournals.orgD
ownloaded from
JPET #98350
26
Figure 3. Higher magnification of myenteric ganglia represented in boxed areas of Figure 2:
COX-1 (A, B) and COX-2 (C, D) were detected in colon from normal (A, C) and DNBS-
treated (B, D) rats. Neurons of myenteric ganglia (arrows). Neurons were immunostained for
COX-1 both in normal (A) and inflamed (B) rat colon without appreciable differences in
cytoplasmatic immunostaining. The weak COX-2 signal observed in myenteric neurons from
normal rats (C) was enhanced in neurons and glial cells of myenteric ganglia of DNBS-treated
rats (D). In rats with colitis, COX-2 immunostaining was observed also in muscle cell nuclei
of longitudinal layer (arrowheads).
Figure 4. Representative tracings showing the contractile responses of longitudinal muscle
preparations of colon obtained from normal rats (upper panel) or animals with DNBS-induced
colitis (lower panel). The colonic preparations were incubated in standard medium and
subjected to transmural electrical stimulation (TES: 0.5 ms, 10 Hz, 30 mA, 10 s) either alone
(CON) or in the presence of indomethacin 1 µM (IND), SC-560 0.1 µM or DFU 1 µM. W,
washing; TES, transmural electrical stimulation; CON, control contractions.
Figure 5. Effects of indomethacin (IND, 1 µM), SC-560 0.1 µM, DFU 1 µM and SC-560 plus
DFU on the contractile responses of longitudinal muscle preparations of colon, obtained from
normal rats (A, C) or animals with DNBS-induced colitis (B, D), under the following
conditions: (A, B) incubation in standard medium and application of transmural electrical
stimulation (TES: 0.5 ms, 10 Hz, 30 mA, 10 s); (C, D) incubation in medium containing
guanethidine 10 µM, L-NAME 100 µM, L-732,138 10 µM, GR-159897 1 µM, SB-218795 1
µM, and application of TES. Each column represents the mean ± SEM value obtained from 8-
10 experiments. *P<0.05: significant difference vs control value.
This article has not been copyedited and formatted. The final version may differ from this version.JPET Fast Forward. Published on February 10, 2006 as DOI: 10.1124/jpet.105.098350
at ASPE
T Journals on February 19, 2021
jpet.aspetjournals.orgD
ownloaded from
JPET #98350
27
Figure 6. Upper panel: representative tracings showing the contractile responses of
longitudinal muscle preparations of colon obtained from normal rats or animals with DNBS-
induced colitis. The colonic preparations were incubated in medium containing tetrodotoxin 1
µM and subjected to stimulation with carbachol 1 µM (CARB), either alone (CON) or in the
presence of indomethacin 1 µM (IND). W, washing; CON, control contractions. Lower panel:
column graph showing the effects of indomethacin (IND, 1 µM), SC-560 0.1 µM, DFU 1 µM
and SC-560 plus DFU on the contractile responses of longitudinal muscle preparations
isolated from normal rats and exposed to carbachol 1 µM in the presence of tetrodotoxin 1
µM. Each column represents the mean ± SEM value obtained from 6 experiments.
Figure 7. Effects of indomethacin (IND, 1 µM), SC-560 0.1 µM, DFU 1 µM and SC-560
plus DFU on the contractile responses of longitudinal muscle preparations of colon obtained
from rats with DNBS-induced colitis subjected to subcutaneous injection of superoxide
dismutase 7 mg/kg/day (A) or S-methylisothiourea 14 mg/kg/day (B) for six days. The
colonic preparations were incubated in standard medium and subjected to transmural
electrical stimulation (TES: 0.5 ms, 10 Hz, 30 mA, 10 s). Each column represents the mean ±
SEM value obtained from 10 experiments. *P<0.05: significant difference vs control value.
SOD, superoxide dismutase; SMT, S-methylisothiourea.
This article has not been copyedited and formatted. The final version may differ from this version.JPET Fast Forward. Published on February 10, 2006 as DOI: 10.1124/jpet.105.098350
at ASPE
T Journals on February 19, 2021
jpet.aspetjournals.orgD
ownloaded from
JPET #98350
28
Table 1. Macroscopic and microscopic damage scores estimated for colon in rats under
normal conditions or after treatment with DNBS, DNBS plus SOD or DNBS plus SMT.
Normal DNBS DNBS+SOD DNBS+SMT
Macroscopic
damage
1.56±0.27 10.32±1.44* 6.47±1.60 *,# 5.98±1.15 *,#
Microscopic
damage
1.19±0.31 7.86±1.22* 4.11±1.03 *,# 4.89±1.17 *,#
Each value represents the mean of 8-10 experiments ± SEM. Significant difference from the
respective values obtained in normal rats: *P<0.05. Significant difference from the respective
values obtained in animals treated with DNBS alone: #P<0.05.
This article has not been copyedited and formatted. The final version may differ from this version.JPET Fast Forward. Published on February 10, 2006 as DOI: 10.1124/jpet.105.098350
at ASPE
T Journals on February 19, 2021
jpet.aspetjournals.orgD
ownloaded from
JPET #98350
β-actin286 bp
COX-2706 bp
NormalColitis
COX-1882 bp
B
0.0
0.1
0.2
0.3
CO
X-1
/β-a
ctin
(ar
bit
rary
un
its)
A
0.0
0.1
0.2
0.3C *
CO
X-2
/β-a
ctin
(ar
bit
rary
un
its)
Figure 1
Normal Colitis
Normal Colitis
COX-1
COX-2
This article has not been copyedited and formatted. The final version may differ from this version.JPET Fast Forward. Published on February 10, 2006 as DOI: 10.1124/jpet.105.098350
at ASPE
T Journals on February 19, 2021
jpet.aspetjournals.orgD
ownloaded from
JPET #98350
100µm
NORMAL COLITIS
A.COX-1 B.COX-1
C.COX-2 D.COX-2
E.NFL F.NFL
G.negative control H.negative control
cm
cm
cm
cm
lmlm
lm lm
lm
lm
lm
lm
cmcm
cmcm
Figure 2
This article has not been copyedited and formatted. The final version may differ from this version.JPET Fast Forward. Published on February 10, 2006 as DOI: 10.1124/jpet.105.098350
at ASPE
T Journals on February 19, 2021
jpet.aspetjournals.orgD
ownloaded from
JPET #98350
NORMAL COLITIS
D.COX-2
A.COX-1
C.COX-2
B.COX-1
100µm
Figure 3
This article has not been copyedited and formatted. The final version may differ from this version.JPET Fast Forward. Published on February 10, 2006 as DOI: 10.1124/jpet.105.098350
at ASPE
T Journals on February 19, 2021
jpet.aspetjournals.orgD
ownloaded from
CON
.W
5 mm
2 min.W
.W
.W
.W
.W
.W
.W
.W
.W
.W.W
Figure 4
NORMAL
COLITIS
CONCON
CON CONCON
IND DFUSC-560
IND DFUSC-560
TES TES TES TES TES TES
TES TES TES TES TES TES
JPET #98350This article has not been copyedited and formatted. The final version may differ from this version.JPET Fast Forward. Published on February 10, 2006 as DOI: 10.1124/jpet.105.098350
at ASPE
T Journals on February 19, 2021
jpet.aspetjournals.orgD
ownloaded from
A. NORMAL
C. NORMAL
B. COLITIS
D. COLITIS
Ch
ang
ein
mot
or
resp
on
ses
toT
ES
(%
)C
han
ge
in m
oto
r re
spo
nse
sto
TE
S (
%)
** *
*
* * *
*
*
*
* **
Figure 5
*
0
30
60
90
120
150
180
210
0
30
60
90
120
150
180
210
0
30
60
90
120
150
180
210
0
30
60
90
120
150
180
210
CON IND SC-560 DFU SC-560+DFU
CON IND SC-560 DFU SC-560+DFU
CON IND SC-560 DFU SC-560+DFU
CON IND SC-560 DFU SC-560+DFU
JPET #98350This article has not been copyedited and formatted. The final version may differ from this version.JPET Fast Forward. Published on February 10, 2006 as DOI: 10.1124/jpet.105.098350
at ASPE
T Journals on February 19, 2021
jpet.aspetjournals.orgD
ownloaded from
CON
.W
5 mm
2 min
CARB 1 µM
.W
.W.W
CARB 1 µMCARB 1 µM
CARB 1 µM
INDCON
IND
Ch
ang
ein
mo
tor
resp
on
seto
carb
ach
ol (
%)
0
20
40
60
80
100
120
Figure 6
NORMAL
COLITIS
CON IND SC-560 DFU SC-560+DFU
NORMAL
JPET #98350This article has not been copyedited and formatted. The final version may differ from this version.JPET Fast Forward. Published on February 10, 2006 as DOI: 10.1124/jpet.105.098350
at ASPE
T Journals on February 19, 2021
jpet.aspetjournals.orgD
ownloaded from
Ch
ang
ein
mo
tor
resp
on
seto
TE
S (
%)
A. COLITIS+SOD
Ch
ang
ein
mo
tor
resp
on
seto
TE
S (
%)
*
*
*
*
*
**
*
0
20
40
60
80
100
120
140
160
180
0
20
40
60
80
100
120
140
160
180
Figure 7
B. COLITIS+SMT
CON IND SC-560 DFU SC-560+DFU
CON IND SC-560 DFU SC-560+DFU
JPET #98350This article has not been copyedited and formatted. The final version may differ from this version.JPET Fast Forward. Published on February 10, 2006 as DOI: 10.1124/jpet.105.098350
at ASPE
T Journals on February 19, 2021
jpet.aspetjournals.orgD
ownloaded from